trial

Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia

NCTId NCT00631722
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 80 (actual)
Sponsored by Peking University
Primary completion 2008-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
80 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2007-05
Primary completion
2008-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Quatiapine FumarateHaloperidol

Sponsors

Peking UniversityLead Sponsor

Investigators

1
Tianmei Si, MDPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
80
Phase
NA
Primary Completion Date
2008-01
Status
COMPLETED
relationships
The graph out of here
drug
Quatiapine Fumarate
drug
Haloperidol
drug
lead_sponsor
Peking University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Tianmei Si, MD
person